You just read:

Endo Agrees to Additional Stay of FDA Litigation Following FDA's Commitment to Use Best Efforts to Finalize Vasopressin Clinical Need Determination By Year End

News provided by

Endo International plc

24 Sep, 2018, 11:00 BST